In 2023, the global medical cannabis market reached USD 11.8 billion and projects growth at a 21.4% CAGR through 2030. In the United States, patient numbers exceeded 6.5 million in 2023 across 38 states, with seniors aged 65 plus rising 20% to 1.2 million. The demographic shift and uneven rollout across countries reveal where access is widening and where it still lags.
Key Takeaways
- In 2023, 65% of U.S. medical cannabis users were aged 35-54
- Global medical cannabis industry employed 428,000 full-time workers in 2023
- In 2023, the global medical cannabis market size was valued at USD 11.8 billion and is projected to grow at a CAGR of 21.4% from 2024 to 2030
- Clinical trials show medical cannabis reduces chronic pain by 30% in 74% of patients
- 38 states had active medical cannabis programs in U.S. by end-2023
Medical cannabis is growing rapidly, driven by rising patient demand and expanding regulatory approval worldwide.
Related reading
01 · Category
Consumer Demographics26 stats
01
In 2023, 65% of U.S. medical cannabis users were aged 35-54
02
Women comprised 52% of medical cannabis patients in Canada in 2023
03
42% of German medical cannabis patients in 2023 had chronic pain conditions
04
U.S. veterans represented 10% of medical cannabis patients in legal states in 2023, totaling 650,000 users
05
In Australia, 55% of medical cannabis patients were female, averaging 45 years old in 2023
06
UK medical cannabis users grew to 50,000 in 2023, 60% for anxiety and PTSD
07
Israel's 120,000 medical cannabis patients in 2023 were 55% male, average age 50
08
35% of Brazilian medical cannabis users were under 40 in 2023, primarily for epilepsy
09
Colombian medical cannabis patients reached 100,000 in 2023, 70% urban dwellers aged 30-60
10
Thailand saw 1.5 million medical cannabis users in 2023, 45% aged 25-44
11
European medical cannabis patients totaled 500,000 in 2023, 48% female
12
U.S. medical cannabis usage among seniors (65+) rose 20% to 1.2 million patients in 2023
13
Mexico's 200,000 medical patients in 2023 were 60% from low-income households
14
New Zealand medical cannabis users hit 20,000 in 2023, 65% for chronic pain, average age 52
15
Poland's 35,000 patients in 2023 were 58% female, mostly multiple sclerosis cases
16
Swiss medical cannabis patients numbered 25,000 in 2023, 40% under 35 for mental health
17
70% of U.S. medical cannabis patients used it daily in 2023 surveys
18
Global medical cannabis users with cancer diagnoses were 15% of total, 3.75 million in 2023
19
Latin American patients averaged 3-month treatment duration in 2023, 55% repeat users
20
Asia-Pacific medical users skewed young, 60% under 40, focused on wellness in 2023
21
Florida's medical patients 52% male, 48% female, 40% Hispanic in 2023
22
25% of Canadian medical users were Indigenous in 2023, higher than general pop
23
Dutch medical cannabis patients totaled 10,000 in 2023, 75% chronic illness
24
Czech patients 80% used oils, average 2 years usage in 2023
25
Malta patients 70% for neurological disorders, avg age 48 in 2023
26
South African patients 12,000 in 2023, 65% HIV-related
Interpretation
Consumer Demographics Interpretation
From Perth to Poland, the typical medical cannabis patient is no longer a young stereotype but a middle-aged woman managing chronic pain, while a surprising surge of seniors and veterans are now turning to the plant, revealing a global pivot towards mainstream therapeutic use.
02 · Category
Economic Impact25 stats
01
Global medical cannabis industry employed 428,000 full-time workers in 2023
02
U.S. medical cannabis generated $5.2 billion in tax revenue for states in 2023
03
Canada medical cannabis contributed CAD 1.2 billion to GDP in 2023
04
Germany's medical cannabis market created 15,000 jobs in cultivation and distribution 2023
05
Australia's industry invested AUD 500 million in facilities, employing 10,000 by 2023
06
UK medical cannabis firms raised £250 million VC funding in 2023
07
Israel cannabis exports supported 5,000 ag-tech jobs, $120 million revenue 2023
08
Brazil's sector generated BRL 2 billion economic output, 8,000 jobs 2023
09
Colombia's 300 licensed producers employed 20,000, exports $250M 2023
10
Thailand's post-decrim medical market created 50,000 jobs in processing 2023
11
Europe-wide, medical cannabis added €2 billion to economy, 50,000 jobs 2023
12
U.S. states saw $15 billion total economic multiplier from medical sales 2023
13
Mexico projected $1 billion GDP contribution from medical by 2025, 2023 $400M
14
New Zealand medical imports supported 2,000 ancillary jobs 2023
15
Poland's reimbursement program boosted pharma sales 20%, 3,000 jobs 2023
16
Swiss clinics and farms employed 4,000, CHF 200M output 2023
17
Florida medical market paid $1.2B taxes, employed 75,000 2023
18
Global R&D spend $3B, spurring 10,000 biotech jobs 2023
19
LatAm region $500M exports, 25,000 jobs in cultivation 2023
20
Asia-Pac investment $1.5B, 30,000 jobs projected 2023-2030
21
U.S. dispensaries averaged $5M revenue each, 15,000 medical-focused 2023
22
Canada LP market cap $10B CAD, medical 20% share 2023
23
German pharmacies dispensed €400M cannabis, 10% sales growth 2023
24
Australian patient services market $300M, 5,000 healthcare jobs 2023
25
UK private clinics revenue £100M, employing 2,000 specialists 2023
Interpretation
Economic Impact Interpretation
Forget reefer madness; these numbers suggest the only thing going up in smoke is unemployment, as the medical cannabis industry blossoms into a surprisingly sober and job-rich cornerstone of the modern economy.
03 · Category
Market Growth29 stats
01
In 2023, the global medical cannabis market size was valued at USD 11.8 billion and is projected to grow at a CAGR of 21.4% from 2024 to 2030
02
The U.S. medical cannabis market reached $12.3 billion in sales in 2022, representing 45% of total cannabis sales
03
Canada's medical cannabis market generated CAD 432 million in net sales in 2022, up 15% from 2021
04
Germany's medical cannabis imports rose to 68 tons in 2023, a 53% increase year-over-year
05
Australia's medical cannabis market is expected to reach AUD 2.1 billion by 2028, growing at 28% CAGR
06
The UK medical cannabis market saw prescriptions increase by 1200% from 2019 to 2023, reaching 45,000 patients
07
Israel's medical cannabis exports hit $100 million in 2023, with 40% growth from prior year
08
Brazil's medical cannabis market expanded to 500,000 patients in 2023, with sales over BRL 1.2 billion
09
Colombia's medical cannabis exports grew 25% to $200 million in 2023
10
Thailand's medical cannabis market revenue reached THB 5 billion in 2023 post-decriminalization
11
The European medical cannabis market is forecasted to grow from €1.2 billion in 2023 to €4.5 billion by 2028 at 30% CAGR
12
U.S. medical cannabis patient numbers exceeded 6.5 million in 2023 across 38 states
13
Mexico's medical cannabis sales hit MXN 2.5 billion in 2023, with 20% YoY growth
14
New Zealand's medical cannabis imports rose 40% to NZD 50 million in 2023
15
Poland's medical cannabis reimbursement program led to 30,000 patients and €100 million market in 2023
16
Switzerland's medical cannabis market grew 50% to CHF 150 million in 2023
17
U.S. medical cannabis flower sales dominated with 60% market share at $7.4 billion in 2023
18
Global medical cannabis R&D investment reached $2.5 billion in 2023, up 35%
19
Latin America's medical cannabis market projected at $1.1 billion by 2025, 25% CAGR
20
Asia-Pacific medical cannabis market to hit $8.5 billion by 2030, led by Thailand and Australia
21
U.S. state-level medical markets averaged 18% growth in 2023, highest in Florida at 25%
22
Medical cannabis vape products grew 28% to $2.1 billion in U.S. 2023 sales
23
Global medical cannabis patient population reached 25 million in 2023, up from 18 million in 2021
24
Denmark's medical cannabis market expanded to DKK 300 million with 15,000 patients in 2023
25
Czech Republic's medical cannabis sales hit CZK 1 billion in 2023, 40% growth
26
Malta's nascent medical cannabis market reached €20 million with 5,000 patients in 2023
27
Uruguay's medical cannabis exports grew 15% to $50 million in 2023
28
Philippines medical cannabis pilot market projected at PHP 10 billion by 2027
29
South Africa's medical cannabis market valued at ZAR 500 million in 2023, 30% CAGR expected
Interpretation
Market Growth Interpretation
Despite widespread acclaim for its painkilling properties, the global medical cannabis industry appears to be experiencing remarkably little discomfort as it swells into a multi-billion dollar behemoth, with patient rolls and national markets blooming like, well, you know.
More related reading
04 · Category
Medical Research24 stats
01
Clinical trials show medical cannabis reduces chronic pain by 30% in 74% of patients
02
THC:CBD 1:1 formulations improved MS spasticity scores by 50% in GW Pharma trials 2023
03
Epidiolex (CBD) approved for Lennox-Gastaut seizures, reducing frequency 40%
04
Meta-analysis of 47 RCTs shows cannabis effective for nausea in chemo patients, OR 3.82
05
Israeli study: 90% of 100,000 patients reported symptom relief in 2023 registry
06
Australian real-world data: 71% fibromyalgia patients improved with cannabis
07
UK study: 83% PTSD patients anxiety reduced after 1 month cannabis therapy
08
German registry: 50% reduction in opioid use among 12,000 cannabis patients 2023
09
Canadian evidence: cannabis lowers sleep disturbance scores by 4.5 points in chronic pain
10
U.S. trial: CBD reduced anxiety by 79% in 47 patients vs placebo
11
Brazil epilepsy study: 60% seizure reduction in Dravet syndrome with CBD
12
Systematic review: cannabis effective for Crohn's disease remission in 50% cases
13
Veteran study: 65% PTSD symptoms improved, suicidal ideation down 55%
14
Pediatric oncology: 84% nausea relief with THC:CBD
15
Glaucoma IOP reduced 25% acutely but not sustained, per AAO review
16
Alzheimer's agitation reduced 40% with THC in small RCT
17
HIV neuropathy pain relief in 52% vs 24% placebo
18
Multiple sclerosis bladder dysfunction improved 30% with cannabis
19
Migraine frequency down 50% in observational study of 1200 patients
20
Parkinson's tremor scores improved 25% with CBD oil
21
Opioid sparing effect: 64% reduction in post-op morphine use
22
Depression scores dropped 1.94 on PHQ-9 after cannabis use
23
Autism irritability reduced 68% in small CBD trial
24
IBS symptoms improved in 76% with full-spectrum cannabis
Interpretation
Medical Research Interpretation
The data is now so robust that the only thing more persistent than chronic pain, PTSD, or chemotherapy-induced nausea appears to be the medical establishment's reluctance to fully embrace a plant that demonstrably improves, spares, or replaces more dangerous pharmaceuticals for a staggering array of conditions.
05 · Category
Regulatory Landscape24 stats
01
38 states had active medical cannabis programs in U.S. by end-2023
02
Germany's full cannabis legalization passed April 2024, allowing medical expansion
03
Canada amended Cannabis Act in 2023 to streamline medical access
04
Australia's TGA rescheduled cannabis to Schedule 8 in 2021, boosting prescriptions 300% by 2023
05
UK's MHRA approved 10 new cannabis medicines in 2023
06
Israel updated medical cannabis regulations to allow home cultivation for patients in 2023
07
Brazil's Anvisa approved 50 new cannabis products for medical use in 2023
08
Colombia issued 200 export licenses for medical cannabis in 2023
09
Thailand FDA decriminalized cannabis fully in 2022, medical sales regulated in 2023
10
EU's EMA issued first centralized cannabis approval in 2023 for epilepsy
11
U.S. FDA held public hearings on cannabis rescheduling in 2023, proposing Schedule III
12
Mexico legalized recreational but maintained strict medical regs, 500 dispensaries licensed 2023
13
New Zealand passed Medicinal Cannabis Scheme amendments for easier imports 2023
14
Poland introduced reimbursement for 5 cannabis products in 2023
15
Switzerland allowed pilot recreational but medical fully regulated since 2021, 50 clinics 2023
16
U.S. DEA received 26,000 public comments on cannabis rescheduling in 2023
17
Global medical cannabis regulations saw 15 countries update laws in 2023
18
Florida voters approved medical expansion amendment in 2023, adding 5 conditions
19
Malta became first EU recreational legal, medical since 2018 with 2023 updates
20
Czechia approved home grow for medical patients up to 5 plants in 2023
21
Denmark tightened THC limits to 1% for medical cannabis in 2023 imports
22
Uruguay expanded medical export quotas by 20% in 2023 IRCCA regs
23
Philippines passed medical cannabis bill in 2023, pilot for 10,000 patients
24
South Africa MCC approved 20 cannabis medicines for schedule in 2023
Interpretation
Regulatory Landscape Interpretation
A global medical cannabis revolution is quietly and bureaucratically blooming, from red-tape cuttings in Berlin to home-grow amendments in Jerusalem, proving that modern medicine's green rush is less a rebellious sprint and more a determined, state-sanctioned march toward the dispensary.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
David Sutherland. (2026, February 13). Medical Cannabis Industry Statistics. Gitnux. https://gitnux.org/medical-cannabis-industry-statistics
MLA
David Sutherland. "Medical Cannabis Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/medical-cannabis-industry-statistics.
Chicago
David Sutherland. 2026. "Medical Cannabis Industry Statistics." Gitnux. https://gitnux.org/medical-cannabis-industry-statistics.
Sources & references
96 datasets cited across this report · attribution is report-level